Lloyd recalls
Lloyd appears in 40 official U.S. recall notices indexed by RecallRadar, most recently on 2013-05-29.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 40 |
|---|---|
| Published | 2012-07-04 to 2013-05-29 |
| By agency | FDA Drug (40) |
| By classification | Class II (40) |
| By status | terminated (40) |
| Distribution named in notices | US |
Recalls
- Levothroid (levothyroxine sodium tablets, USP) , 125 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Levothroid (levothyroxine sodium tablets, USP), 200 mcg, RX only, 100 tablets per bottle
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.175 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Levothroid (levothyroxine sodium tablets, USP), 88 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St.…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Levothroid (levothyroxine sodium tablets, USP), 150 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St.…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Levothroid (levothyroxine sodium tablets, USP) , 75 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St.…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St.…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.200 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Levothroid (levothyroxine sodium tablets, USP), 100 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St.…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.100 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Levothroid (levothyroxine sodium tablets, USP), 175 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St.…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Levothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St.…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Levothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St.…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Lloyd Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
FDA Drug · Class II · 2013-05-29 · Lloyd
Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected. - Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand…
FDA Drug · Class II · 2013-01-02 · Lloyd
Reason: Subpotent; 9-month stability interval - Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceutic…
FDA Drug · Class II · 2013-01-02 · Lloyd
Reason: Subpotent; 9-month stability interval - Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand…
FDA Drug · Class II · 2013-01-02 · Lloyd
Reason: Subpotent; 9-month stability interval - Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceutic…
FDA Drug · Class II · 2013-01-02 · Lloyd
Reason: Subpotent; 9-month stability interval - Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured for Forest Pharmaceutic…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceutic…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Levothroid (levothyroxine sodium tablets, USP), 88 mcg., 100-count bottles, Rx only, NDC 0456-1329-01, Manufactured for Forest Pharmaceutic…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Levothroid (levothyroxine sodium tablets, USP), 300 mcg., 100-count bottles, Rx only, NDC 0456-1328-01, Manufactured for Forest Pharmaceuti…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Levothroid (levothyroxine sodium tablets, USP), 137 mcg., 100-count bottles, Rx only, NDC 0456-1331-01, Manufactured for Forest Pharmaceuti…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Levothroid (levothyroxine sodium tablets, USP), 112 mcg., 100-count bottles, Rx only, NDC 0456-1330-01, Manufactured for Forest Pharmaceuti…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenand…
FDA Drug · Class II · 2012-12-12 · Lloyd
Reason: cGMP Deviations; does not meet in process specification requirements - Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceutic…
FDA Drug · Class II · 2012-07-04 · Lloyd
Reason: Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval. - Thyro-Tab.075 mg., packaged in bulk drums for repackaging
FDA Drug · Class II · 2012-07-04 · Lloyd
Reason: Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval. - Levothroid (levothyroxine sodium tablets, USP), 50 mcg., packaged in 100-ct. bottles, RX, NDC 0456-1321-01
FDA Drug · Class II · 2012-07-04 · Lloyd
Reason: Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval. - Thyro-Tab 0.050mg., packaged in bulk drums for repackaging
FDA Drug · Class II · 2012-07-04 · Lloyd
Reason: Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.